Mediation analyses of the effect of ertugliflozin on hospitalisation for heart failure in patients with type 2 diabetes and atherosclerotic cardiovascular disease from the VERTIS CV trial Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Segar, M. W.; Pandey, A.; Cherney, D. Z. I.; Cannon, C. P.; Cosentino, F.; Dagogo-Jack, S.; Pratley, R. E.; Shih, W. J.; Frederich, R.; Cater, N. B.; Maldonado, M.; Liu, J.; Liu, C.; Pong, A.; McGuire, D. K.

authors

Publication Date

  • October 1, 2021

webpage

published in

category

start page

  • 2649

end page

  • 2649

volume

  • 42